Abstract:Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal lung disease with obscure pathogenesis. Increasing evidence suggests that cellular senescence is an important mechanism underlying in IPF. Clinical treatment with drugs, such as pirfenidone and nintedanib, reduces the risk of acute exacerbation and delays the decline of pulmonary function in patients with mild to moderate pulmonary fibrosis, and with adverse reactions. Hesperidin was previously shown to alleviate pulmonary fibrosis in rats by attenuating the inflammation response. Our previous research indicated that the Citrus alkaline extracts, hesperidin as the main active ingredient, could exert anti-pulmonary fibrosis effects by inhibiting the senescence of lung fibroblasts. However, whether hesperidin could ameliorate pulmonary fibrosis by inhibiting fibroblast senescence needed further study. Purpose: This work aimed to investigate whether and how hesperidin can inhibit lung fibroblast senescence and thereby alleviate pulmonary fibrosis METHODS: Bleomycin was used to establish a mouse model of pulmonary fibrosis and doxorubicin was used to establish a model of cellular senescence in MRC-5 cells in vitro. The therapeutic effects of hesperidin on pulmonary fibrosis using haematoxylin-eosin staining, Masson staining, enzyme-linked immunosorbent assay, immunohistochemistry, western blotting and quantitative Real-Time PCR. The anti-senescent effect of hesperidin in vivo and in vitro was assessed by western blotting, quantitative Real-Time PCR and senescence-associated β-galactosidase RESULTS: We demonstrated that hesperidin could alleviate bleomycin-induced pulmonary fibrosis in mice. The expression level of senescence marker proteins p53, p21, and p16 was were downregulated, along with the myofibroblast marker α-SMA. The number of senescence-associated β-galactosidase-positive cells was significantly reduced by hesperidin intervention in vivo and in vitro. In addition, hesperidin could inhibit the IL6/STAT3 signaling pathway. Furthermore, suppression of the IL-6/STAT3 signaling pathway by pretreatment with the IL-6 inhibitor LMT-28 attenuating effect of hesperidin on fibroblast senescence in vitro. Conclusions: These data illustrated that hesperidin may be potentially used in the treatment of IPF based on its ability to inhibit lung fibroblast senescence.

Effects of Hesperetin on Platelet-Derived Growth Factor-Bb-induced Pulmonary Artery Smooth Muscle Cell Proliferation

Effect of hesperetin on cardiac fibroblast proliferarion induced by TGF-β1

GW25-e4278 Hesperetin blocks the proliferation of pulmonary artery smooth muscle cells induced by platelet-derived growth factor-BB

Involvement of CapG in Proliferation and Apoptosis of Pulmonary Arterial Smooth Muscle Cells and in Hypoxia-Induced Pulmonary Hypertension Rat Model

Hesperitin Derivative-11 Suppress Hepatic Stellate Cell Activation and Proliferation by Targeting PTEN/AKT Pathway.

Hesperetin, A Bioflavonoid, Inhibits Rat Aortic Vascular Smooth Muscle Cells Proliferation by Arresting Cell Cycle

Effect of mibefradil on proliferation of human pulmonary artery smooth muscle cells induced by platelet-derived growth factor

PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway

The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.

Role of 20-Hydroxyeicosatetraenoic Acid in Pulmonary Hypertension and Proliferation of Pulmonary Arterial Smooth Muscle Cells.

Effects of Hesperetin on Proliferation and Apoptosis of Pancreatic Cancer Panc-1 Cells and Its Mechanism

Effect of Nuclear Transcription Factor Kappab Pathway on Proliferation in Rat Pulmonary Artery Smooth Muscle Cells Induced by Platelet-Derived Growth Factor

Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis

Dual Pigment Epithelium-derived Factor and Hepatocyte Growth Factor Overexpression: A New Therapy for Pulmonary Hypertension.

Inhibitory Effects of Hydroxysafflor Yellow A on PDGF‑BB‑induced Proliferation and Migration of Vascular Smooth Muscle Cells Via Mediating Akt Signaling.

Salidroside blocks the proliferation of pulmonary artery smooth muscle cells induced by platelet‑derived growth factor‑BB.

Activation of PPARγ Inhibits HDAC1-mediated Pulmonary Arterial Smooth Muscle Cell Proliferation and Its Potential Mechanisms.

Effect of Hesperidin on TGF-beta1/Smad Signaling Pathway in HSC.

Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats

Hesperetin Inhibits TGF-β1-Induced Migration and Invasion of Triple Negative Breast Cancer MDA-MB-231 Cells via Suppressing Fyn/Paxillin/RhoA Pathway

Hesperetin Protects Against Cardiac Remodelling Induced by Pressure Overload in Mice.